Halomethanes
![eMolecules AstaTech / 1H-BENZO[D][123]TRIAZOLE-6-SULFONIC ACID / 0.25g / 444389076 / C16678 / 97.000 / 91159-88-5 / [null] / 199.180 / C6H5N3O3S](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502486787.JPG-250.jpg)
eMolecules AstaTech / 1H-BENZO[D][123]TRIAZOLE-6-SULFONIC ACID / 0.25g / 444389076 / C16678 / 97.000 / 91159-88-5 / [null] / 199.180 / C6H5N3O3S
AstaTech / 1H-BENZO[D][123]TRIAZOLE-6-SULFONIC ACID / 0.25g / 444389076 / C16678 / 97.000 / 91159-88-5 / [null] / 199.180 / C6H5N3O3S
Apexbio Technology LLC 360A iodide 737763-37-0 10mg
360A iodide (CAS 737763-37-0) is a 2 6-pyridine-dicarboxamide derivative that acts as a selective ligand for G-quadruplex DNA structures By stabilizing telomeric G-quadruplexes 360A inhibits telomerase activity and induces alterations in cell cycle progression notably causing S-phase accumulation in ATM-proficient EBV-lymphocytes Its mechanism of action involves promoting sister telomere fusions via DNA-PKcs-dependent non-homologous end joining (NHEJ) as well as triggering NHEJ and homologous recombination (HR) pathways at telomeres which disrupt mitotic progression 360A has been shown to preferentially bind telomeric G-quadruplex DNA over duplex DNA and to delay growth in HT1080 tumor cells This compound is valuable for investigating telomere biology DNA damage response and G-quadruplex-mediated genomic stability
Sigma Aldrich Fine Chemicals Biosciences Iodomethane Pharmaceutical
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Medchemexpress LLC Ro8191 | 691868-88-9 | 98.8% | 373.21 g/mol | C14H5F6N5O | 100 MG
RO8191 is an orally active small-molecule interferon receptor agonist that binds IFNα/β receptor and activates JAK/STAT signalling, showing antiviral activity in HCV replicon assays.
- Orally active IFN receptor agonist that activates JAK/STAT and ISG expression.
- Shown activity in HCV replicon assays (IC50 ≈ 200 nM) and reported anti-HBV effects.
- Chemical formula C14H5F6N5O; molecular weight 373.21 g/mol; CAS 691868-88-9.
- Purity reported ~98.8% (datasheet); supplier documentation also lists ≥99.0%.
- Store under inert gas at -20°C; in solvent store at -80°C (6 months) or -20°C (1 month) under nitrogen.
- Intended for research use only; not for human or veterinary use.
Medchemexpress LLC Beperidium iodide | 86434-57-3 | MFCD00866899 | 100.0% | 527.44 g/mol | C23H34IN3O3 | 5 MG
Beperidium iodide is the iodide salt of a bioactive compound used as a competitive antagonist of acetylcholine receptors. It is supplied as a small, high-purity research reagent with a reported pA2 of 7.93, intended for use as a pharmacological probe in studies of cholinergic signaling.
- Competitive antagonist of acetylcholine receptors with reported pA2 = 7.93.
- High purity (99.97%) suitable for analytical and experimental use.
- Molecular formula C23H34IN3O3 and molecular weight 527.44 g/mol.
- Available as a 5 mg research pack for laboratory studies.
- Provided as the iodide salt for improved stability and handling.
eMolecules ChemScene / 4-Chloro-2-fluorobenzothioamide / 250mg / 572194186 / CS-0114061 / 0.000 / 1343722-88-2 / MFCD17290209 / 189.630 / C7H5ClFNS
ChemScene / 4-Chloro-2-fluorobenzothioamide / 250mg / 572194186 / CS-0114061 / 0.000 / 1343722-88-2 / MFCD17290209 / 189.630 / C7H5ClFNS
eMolecules ChemScene / 4-Chloro-N-hydroxybenzamide / 100mg / 714103995 / CS-0145140 / 0.000 / 1613-88-3 / MFCD03551074 / 171.580 / C7H6ClNO2
ChemScene / 4-Chloro-N-hydroxybenzamide / 100mg / 714103995 / CS-0145140 / 0.000 / 1613-88-3 / MFCD03551074 / 171.580 / C7H6ClNO2
eMolecules Pharmablock / 1-(methylaminomethyl)cyclobutanol / 25mg / 587659667 / PBU6011 / 0.000 / 1461706-88-6 / MFCD24076247 / 115.176 / C6H13NO
Pharmablock / 1-(methylaminomethyl)cyclobutanol / 25mg / 587659667 / PBU6011 / 0.000 / 1461706-88-6 / MFCD24076247 / 115.176 / C6H13NO
Apexbio Technology LLC 360A iodide 737763-37-0 50mg
360A iodide (CAS 737763-37-0) is a 2 6-pyridine-dicarboxamide derivative that acts as a selective ligand for G-quadruplex DNA structures By stabilizing telomeric G-quadruplexes 360A inhibits telomerase activity and induces alterations in cell cycle progression notably causing S-phase accumulation in ATM-proficient EBV-lymphocytes Its mechanism of action involves promoting sister telomere fusions via DNA-PKcs-dependent non-homologous end joining (NHEJ) as well as triggering NHEJ and homologous recombination (HR) pathways at telomeres which disrupt mitotic progression 360A has been shown to preferentially bind telomeric G-quadruplex DNA over duplex DNA and to delay growth in HT1080 tumor cells This compound is valuable for investigating telomere biology DNA damage response and G-quadruplex-mediated genomic stability
eMolecules Ambeed / 34-difluorobenzoylchloride / 5g / 569096044 / A378696 / / 76903-88-3 / MFCD00009930 / 176.550 / C7H3ClF2O
Ambeed / 34-difluorobenzoylchloride / 5g / 569096044 / A378696 / / 76903-88-3 / MFCD00009930 / 176.550 / C7H3ClF2O